Neuroprotective effects of agmatine on oxygen-glucose deprived primary-cultured astrocytes and nuclear translocation of nuclear factor-kappa B

Brain Research

Volumn 1281, Issue , 2009, Pages 64-70

  Lee, Won Taek ^a   Hong, Samin ^a   Yoon, Sung Hwan ^a   Kim, Jae Hwan ^a   Park, Kyung Ah ^a   Seong, Gong Je ^a   Lee, Jong Eun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Agmatine; Astrocyte; Ischemia; Neuroprotection

Indexed keywords

AGMATINE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; LIPOCORTIN 5; OXYGEN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; FLOW CYTOMETRY; IMMUNOBLOTTING; ISCHEMIA; MORPHOLOGY; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ACTIVE TRANSPORT, CELL NUCLEUS; AGMATINE; ANIMALS; ANNEXIN A5; ASTROCYTES; BISBENZIMIDAZOLE; BLOTTING, WESTERN; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; FLOW CYTOMETRY; GLUCOSE; L-LACTATE DEHYDROGENASE; MICE; MICE, INBRED ICR; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PHOSPHORYLATION; PROPIDIUM;

EID: 67649394099     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.05.046     Document Type: Article

References (53)

1. Abbott N.J., Rönnbäck L., and Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7 (2006) 41-53
2. Benarroch E.E. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo. Clin. Proc. 80 (2005) 1326-1338
3. Berry M., Maxwell W.L., Logan A., Mathewson A., McConnell P., Ashhurst D.E., and Thomas GH. Deposition of scar tissue in the central nervous system. Acta Neurochir. Suppl. (Wien). 32 (1983) 31-53
4. Brown A.M., Sickmann H.M., Fosgerau K., Lund T.M., Schousboe A., Waagepetersen H.S., and Ransom B.R. Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter. J. Neurosci. Res. 79 (2005) 74-80
5. Cavallini L., Francesconi M.A., Zoccarato F., and Alexandre A. Involvement of nuclear factor-kappa B (NF-kappaB) activation in mitogen-induced lymphocyte proliferation: inhibitory effects of lymphoproliferation by salicylates acting as NF-kappaB inhibitors. Biochem. Pharmacol. 62 (2001) 141-147
6. Chen Y., and Swanson R.A. Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 23 (2003) 137-149
7. de Los Santos T., Diaz-San Segundo F., and Grubman MJ. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J. Virol. 81 (2007) 12803-12815
8. Dudkowska M., Lai J., Gardini G., Stachurska A., Grzelakowska-Sztabert B., Colombatto S., and Manteuffel-Cymborowska M. Agmatine modulates the in vivo biosynthesis and interconversion of polyamines and cell proliferation. Biochim. Biophys. Acta 1619 (2003) 159-166
9. Fitch M.T., Doller C., Combs C.K., Landreth G.E., and Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 19 (1999) 8182-8198
10. Galea E., Regunathan S., Eliopoulos V., Feinstein D.L., and Reis D.J. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem. J. 316 (1996) 247-249
11. Gilad G.M., and Gilad V.H. Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats. Neurosci. Lett. 296 (2000) 97-100
12. Gilad G.M., Salame K., Rabey J.M., and Gilad V.H. Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci. 58 (1996) 41-46 PL
13. Goldstein G.W. Endothelial cell-astrocyte interactions. A cellular model of the blood-brain barrier. Ann. N. Y. Acad. Sci. 529 (1988) 31-39
14. Haber M., Zhou L., and Murai K.K. Cooperative astrocyte and dendritic spine dynamics at hippocampal excitatory synapses. J. Neurosci. 26 (2006) 8881-8891
15. Halaris A., and Plietz J. Agmatine: metabolic pathway and spectrum of activity in brain. CNS. Drugs. 21 (2007) 885-900
16. Hong S., Lee J.E., Kim C.Y., and Seong G.J. Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC. Neurosci. 8 (2007) 81
17. Hong S., Park K., Kim C.Y., and Seong GJ. Agmatine inhibits hypoxia-induced TNF-alpha release from cultured retinal ganglion cells. Biocell. 32 (2008) 201-205
18. Hong S., Kim C.Y., Lee J.E., and Seong G.J. Agmatine protects cultured retinal ganglion cells from tumor necrosis factor-alpha-induced apoptosis. Life. Sci. 84 (2009) 28-32
19. Ishibashi Y., and Nishikawa A. Role of nuclear factor-kappa B in the regulation of intercellular adhesion molecule 1 after infection of human bronchial epithelial cells by Bordetella pertussis. Microb. Pathog. 35 (2003) 169-177
20. Jakovcevic D., and Harder D.R. Role of astrocytes in matching blood flow to neuronal activity. Curr. Top. Dev. Biol. 79 (2007) 75-97
21. Kim J.H., Yenari M.A., Giffard R.G., Cho S.W., Park K.A., and Lee J.E. Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Exp. Neurol. 189 (2004) 122-130
22. Kolesnikov Y., Jain S., and Pasternak GW. Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol. 296 (1996) 17-22
23. Koh J., and Choi D.W. Quantitative determination of glutamine mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods. 20 (1987) 83-90
24. Kotil K., Kuscuoglu U., Kirali M., Uzun H., Akçetin M., and Bilge T. Investigation of the dose-dependent neuroprotective effects of agmatine in experimental spinal cord injury: a prospective randomized and placebo-control trial. J. Neurosurg. Spine. 4 (2006) 392-399
25. Lee J.E., Kim C.Y., Giaccia A.J., and Giffard R.G. The E6 and E7 genes of human papilloma virus-type 16 protect primary astrocyte cultures from injury. Brain Res. 795 (1998) 10-16
26. Lee G.T., and Cho Y.D. Regulation of fibronectin levels by agmatine and spermine in mesangial cells under high-glucose conditions. Diabetes Res. Clin. Pract. 66 (2004) 119-128
27. Liang Z.Q., Li Y.L., Zhao X.L., Han R., Wang X.X., Wang Y., Chase T.N., Bennett M.C., and Qin Z.H. NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53. Brain Res. 1145 (2007) 190-203
28. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., and Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263 (1994) 966-969
29. Li L., Lundkvist A., Andersson D., Wilhelmsson U., Nagai N., Pardo A.C., Nodin C., Ståhlberg A., Aprico K., Larsson K., Yabe T., Moons L., Fotheringham A., Davies I., Carmeliet P., Schwartz J.P., Pekna M., Kubista M., Blomstrand F., Maragakis N., Nilsson M., and Pekny M. Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 28 (2008) 468-481
30. Nadkarni S., and Jung P. Modeling synaptic transmission of the tripartite synapse. Phys. Biol. 4 (2007) 1-9
31. Naumann M. Nuclear factor-kappa B activation and innate immune response in microbial pathogen infection. Biochem. Pharmacol. 60 (2000) 1109-1114
32. Olmos G., DeGregorio-Rocasolano N., Paz Regalado M., Gasull T., Assumpció Boronat M., Trullas R., Villarroel A., Lerma J., and García-Sevilla J.A. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br. J. Pharmacol. 127 (1999) 1317-1326
33. O Riordan J.M., Abdel-latif M.M., Ravi N., McNamara D., Byrne P.J., McDonald G.S., Keeling P.W., Kelleher D., and Reynolds J.V. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am. J. Gastroenterol. 100 (2005) 1257-1264
34. Panet H., Barzilai A., Daily D., Melamed E., and Offen D. Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells. J. Neurochem. 77 (2001) 391-398
35. Pellerin L., Bouzier-Sore A.K., Aubert A., Serres S., Merle M., Costalat R., and Magistretti P.J. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia 55 (2007) 1251-1262
36. Perez Velazquez J.L., Kokarovtseva L., Sarbaziha R., Jeyapalan Z., and Leshchenko Y. Role of gap junctional coupling in astrocytic networks in the determination of global ischaemia-induced oxidative stress and hippocampal damage. Eur. J. Neurosci. 23 (2006) 1-10
37. Qiu W.W., and Zheng R.Y. Neuroprotective effects of receptor imidazoline 2 and its endogenous ligand agmatine. Neurosci. Bull. 22 (2006) 187-191
38. Ransom B.R., and Fern R. Does astrocytic glycogen benefit axon function and survival in CNS white matter during glucose deprivation?. Glia 21 (1997) 134-141
39. Regunathan S., and Piletz J.E. Regulation of inducible nitric oxide synthase and agmatine synthesis in macrophages and astrocytes. Ann. N. Y. Acad. Sci. 1009 (2003) 20-29
40. Rossi D.J., Brady J.D., and Mohr C. Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci. 10 (2007) 1377-1386
41. Saadane A., Soltys J., and Berger M. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation. J. Allergy Clin. Immunol. 117 (2006) 1163-1169
42. Stevens B. Neuron-astrocyte signaling in the development and plasticity of neural circuits. Neurosignals 16 (2008) 278-288
43. Sugiura T., Tsutsui H., Takaoka M., Kobuchi S., Hayashi K., Fujii T., and Matsumura Y. Protective effect of agmatine on ischemia/reperfusion-induced renal injury in rats. J. Cardiovasc. Pharmacol. 51 (2008) 223-230
44. Suh S.W., Bergher J.P., Anderson C.M., Treadway J.L., Fosgerau K., and Swanson R.A. Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide). J. Pharmacol. Exp. Ther. 321 (2007) 45-50
45. Su R.B., Li J., and Qin B.Y. A biphasic opioid function modulator: agmatine. Acta Pharmacol. Sin. 24 (2003) 631-636
46. Swanson R.A., Ying W., and Kauppinen T.M. Astrocyte influences on ischemic neuronal death. Curr. Mol. Med. 4 (2004) 193-205
47. Vermes I., Haanen C., Steffens-Nakken H., and Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 184 (1995) 39-51
48. Wang W.P., Iyo A.H., Miguel-Hidalgo J., Regunathan S., and Zhu M.Y. Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons. Brain Res. 1084 (2006) 210-216
49. Wroblewski F., and Ladue J.S. Lactic dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med. 90 (1955) 210-213
50. Yang X.C., and Reis D.J. Agmatine selectively blocks the N-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J. Pharmacol. Exp. Ther. 288 (1999) 544-549
51. Yu C.G., Marcillo A.E., Fairbanks C.A., Wilcox G.L., and Yezierski R.P. Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport. 11 (2000) 3203-3207
52. Zhu M.Y., Piletz J.E., Halaris A., and Regunathan S. Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells. Cell. Mol. Neurobiol. 23 (2003) 865-872
53. Zhu M.Y., Wang W.P., Cai Z.W., Regunathan S., and Ordway G. Exogenous agmatine has neuroprotective effects against restraint-induced structural changes in the rat brain. Eur. J. Neurosci. 27 (2008) 1320-1332